The shareholders’ account has achieved of 0.96 for 2024 comparing to 0.95 for the year 2023 with growth ration 1%: Chairman ...
Annual Results/Annual ReportSuccessful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance 28.03.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of this ...
Overview of 2024 annual results? ? Consolidated net profit was EUR 82.1 million (EUR 77.4 million in 2023)? Proposed allocation of profit submitted to the Annual General Meeting on 13 May 2025:?gross ...
LAHORE: Chief Minister Punjab Maryam Nawaz Sharif chaired 24th Provincial Cabinet meeting which approved the longest agenda ...
TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Jeremy Feffer - Managing Director, LifeSci Advisors Mary Szela - President & Chief Executive ...
Built on the Rapid Payments Programme (RPP) rails, PayShap has emerged as a key product driving digital transactions, fostering financial inclusion, and accelerating the country’s shift towards a ...
On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...
AMG Critical Materials N.V. ('AMG', EURONEXT AMSTERDAM: 'AMG') has published its Agenda and Explanatory Notes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback